SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies

Eur J Epidemiol. 2023 Mar;38(3):237-242. doi: 10.1007/s10654-023-00965-x. Epub 2023 Feb 4.

Abstract

Neither vaccination nor natural infection result in long-lasting protection against SARS-COV-2 infection and transmission, but both reduce the risk of severe COVID-19. To generate insights into optimal vaccination strategies for prevention of severe COVID-19 in the population, we extended a Susceptible-Exposed-Infectious-Removed (SEIR) mathematical model to compare the impact of vaccines that are highly protective against severe COVID-19 but not against infection and transmission, with those that block SARS-CoV-2 infection. Our analysis shows that vaccination strategies focusing on the prevention of severe COVID-19 are more effective than those focusing on creating of herd immunity. Key uncertainties that would affect the choice of vaccination strategies are: (1) the duration of protection against severe disease, (2) the protection against severe disease from variants that escape vaccine-induced immunity, (3) the incidence of long-COVID and level of protection provided by the vaccine, and (4) the rate of serious adverse events following vaccination, stratified by demographic variables.

Keywords: COVID-19; Control measures; Coronavirus; Herd immunity; Immunology; Infection; Influenza; Population modelling; Respiratory infections; SARS-CoV-2 pandemic; Vaccine effectiveness; Vaccines.

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • Post-Acute COVID-19 Syndrome
  • SARS-CoV-2
  • Vaccination
  • Vaccines*

Substances

  • Vaccines